Evoke Pharma Study Reports Positive Results of Metoclopramide Nasal Spray for Gastroparesis in Diabetics Read more about Evoke Pharma Study Reports Positive Results of Metoclopramide Nasal Spray for Gastroparesis in Diabetics
Evoke Pharma to Present at Biotech Showcase(TM) 2014 Read more about Evoke Pharma to Present at Biotech Showcase(TM) 2014
Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations Read more about Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations
Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis Read more about Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis
Evoke Pharma Reports Third Quarter 2013 Results Read more about Evoke Pharma Reports Third Quarter 2013 Results
Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2013 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2013 Financial Results
Evoke Pharma Announces Full Exercise of Underwriters' Over-Allotment Option Read more about Evoke Pharma Announces Full Exercise of Underwriters' Over-Allotment Option
Evoke Pharma Announces Closing of Initial Public Offering of 2,100,000 Shares of Common Stock Read more about Evoke Pharma Announces Closing of Initial Public Offering of 2,100,000 Shares of Common Stock
Evoke Pharma Announces Pricing of Initial Public Offering of 2,100,000 Shares of Common Stock Read more about Evoke Pharma Announces Pricing of Initial Public Offering of 2,100,000 Shares of Common Stock